Bcr-Abl and Ras in Cml Evolution, Phenotype, Prognosis

Lebowitz, Paul

Abstract

Funding Agency

• Agency: National Institute of Health (NIH)
• Institute: National Cancer Institute (NCI)
• Type: Research Project (R01)
• Project #: 5R01CA049238-03
• Application #: 3193271
• Study Section: Pathology B Study Section (PTHB)
• Project Start: 1989-01-09
• Project End: 1992-12-31
• Budget Start: 1991-01-01
• Budget End: 1992-12-31
• Support Year: 3
• Fiscal Year: 1991

Institution

• Name: Yale University
• Type: Schools of Medicine
• DUNS #: 082359691
• City: New Haven
• State: CT
• Country: United States
• Zip Code: 06520

Publications

Morris, S W; Daniel, L; Ahmed, C M et al. (1990) Relationship of bcr breakpoint to chronic phase duration, survival, and blast crisis lineage in chronic myelogenous leukemia patients presenting in early chronic phase. Blood 75:2035-41